Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitris G Placantonakis

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Molecular Cancer Therapeutics|July 5, 2021
Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or MeningiomaMatthias A Karajannis, Audrey Mauguen, Ekrem Maloku, et al.
Neuro-Oncology Advances|July 10, 2020
Expression profiling of the adhesion G protein-coupled receptor GPR133 (ADGRD1) in glioma subtypesJoshua D Frenster, Michael Kader, Scott Kamen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2018
Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase-mutant GliomaMarissa Spino, Sylvia C Kurz, Luis Chiriboga, et al.
Neuro-Oncology|January 20, 2024
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomasKristyn Galbraith, Mekka Garcia, Siyu Wei, et al.
Neuro-Oncology Advances|May 25, 2022
Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent <i>IDH</i> wild-type glioblastomaJohn F de Groot, Albert H Kim, Sujit Prabhu, et al.
Cell Reports|November 8, 2023
The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerabilityNiklas Ravn-Boess, Nainita Roy, Takamitsu Hattori, et al.
Nature Communications|July 22, 2018
Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastomaMatija Snuderl, Kasthuri Kannan, Elke Pfaff, et al.
Cell Reports|November 2, 2017
Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2Aram S Modrek, Danielle Golub, Themasap Khan, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Purinergic signaling promotes gliomagenesis through nuclear calcium transientsShuai Wang, Jenna Richter, Claire D Kim, et al.
BMC Medical Genomics|April 27, 2019
Sequencing and curation strategies for identifying candidate glioblastoma treatmentsMayu O Frank, Takahiko Koyama, Kahn Rhrissorrakrai, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Molecular Cancer Therapeutics|July 5, 2021
Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or MeningiomaMatthias A Karajannis, Audrey Mauguen, Ekrem Maloku, et al.
Neuro-Oncology Advances|July 10, 2020
Expression profiling of the adhesion G protein-coupled receptor GPR133 (ADGRD1) in glioma subtypesJoshua D Frenster, Michael Kader, Scott Kamen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2018
Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase-mutant GliomaMarissa Spino, Sylvia C Kurz, Luis Chiriboga, et al.
Neuro-Oncology|January 20, 2024
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomasKristyn Galbraith, Mekka Garcia, Siyu Wei, et al.
Neuro-Oncology Advances|May 25, 2022
Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent <i>IDH</i> wild-type glioblastomaJohn F de Groot, Albert H Kim, Sujit Prabhu, et al.
Cell Reports|November 8, 2023
The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerabilityNiklas Ravn-Boess, Nainita Roy, Takamitsu Hattori, et al.
Nature Communications|July 22, 2018
Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastomaMatija Snuderl, Kasthuri Kannan, Elke Pfaff, et al.
Cell Reports|November 2, 2017
Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2Aram S Modrek, Danielle Golub, Themasap Khan, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Purinergic signaling promotes gliomagenesis through nuclear calcium transientsShuai Wang, Jenna Richter, Claire D Kim, et al.
BMC Medical Genomics|April 27, 2019
Sequencing and curation strategies for identifying candidate glioblastoma treatmentsMayu O Frank, Takahiko Koyama, Kahn Rhrissorrakrai, et al.
Pageof 12